Public Benefit as Bootstrapping
Where we are, where we’ve come from, where we’re headed
Zach Haigney
By now, I am sure you've heard that TheraPsil, the Canadian non-profit advocating on behalf of palliative patients for compassionate use of psilocybin …
Zach Haigney
Policy Updates Compassionate Use Milestone Yesterday the psychedelic world awaited with bated breath the announcement from Canadian Health Minister Pat…
Zach Haigney
Announcing a New Project: The Trip Report Community In the last few months, we’ve seen a wave of psychedelic companies form and some have even gone pub…
Zach Haigney
Earlier today I published a post citing two stories about Christian Angermayer's involvement in a transaction unrelated to the psychedelic ecosystem. T…
Zach Haigney
Follow up: Synthesis/Manufacturing Conundrum At every level of education, teachers encourage students to ask questions when they don't understand somet…
Zach Haigney
MindMed Update MindMed Concludes Phase 1 dosing of 18-MC: “Mind Medicine… has concluded dosing in a Phase 1 Single Ascending Dose (SAD) study of 18-MC.…
Zach Haigney
See all